New Tumor Evaluation Modality
Veristat was brought on to write a sponsor’s protocol for a novel therapy that injects treatment into solid tumors. The application of a set of nuanced response criteria required information collected from injected lesions and non-injected lesions to determine a tumor’s response to the treatment.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.